EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity

Xiaorui Geng iD, Silan Liu, Yuanwei Pan, Yun Ge iD, Lang Rao iD

Proceedings of the National Academy of Sciences · 26.05.2026 · 123 (21)

DOI: 10.1073/pnas.2529792123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 14.05.2026. Verfasst von Xiaorui Geng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China. Hauptthemen laut MEDLINE: Glycocalyx, Cell Membrane, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Medical Research Fund, MOST | National Natural Science Foundation of China (NSFC), National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor glycocalyx forms a protective shield that masks checkpoint proteins and compromises the efficacy of immunotherapies. While the bacterial protease StcE can degrade this barrier by cleaving O-glycosylated mucin domains, its therapeutic potential is hindered by off-target toxicity and high immunogenicity. To overcome these limitations, we developed a biomimetic platform of cell membrane fusion nanovesicles (FNVs) that codisplay StcE and CD47 nanobodies (nCD47) for spatially controlled glycocalyx degradation and enhanced checkpoint blockade. Using the SpyTag/SpyCatcher system, we generated StcE-displaying NVs, which were then fused with nCD47-displaying NVs. The resulting StcE-nCD47-FNVs retained potent mucin-hydrolyzing activity and exhibited well-defined physicochemical properties. By removing the mucin barrier, StcE-nCD47-FNVs significantly enhanced nCD47 binding to CD47 on tumor cells, thereby potentiating antitumor immune responses. More importantly, benefiting from prolonged circulation of FNVs and tumor targeting of nCD47, the StcE-nCD47-FNV platform demonstrated superior tumor accumulation and biosafety compared to free StcE. In murine models of colorectal and breast cancer, StcE-nCD47-FNVs significantly suppressed tumor growth and metastasis by remodeling the tumor microenvironment, as evidenced by increased M1 macrophage polarization and CD8 + T cell infiltration. By integrating glycocalyx engineering with vesicle nanotechnology, StcE-nCD47-FNVs offer a safe, robust, and versatile strategy to breach the tumor glycocalyx for next-generation cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycocalyxCell MembraneNeoplasmsAnimalsMiceHumansCell Line, TumorCD47 AntigenImmunotherapyFemaleNanoparticles

Stichwörter der Autor:innen

biomaterialscancer immunotherapychemical biologydrug deliveryglycoengineering

Substanzen

CD47 Antigen

Autor:innen und Institutionen

  • Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China.
  • Shenzhen Medical Academy of Research and Translation, Shenzhen 518107, China.
  • Westlake University, Hangzhou 310030, China.
  • State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China.

ORCID-Profile: Xiaorui Geng, Yun Ge, Lang Rao

Förderung

  • Shenzhen Medical Research Fund
  • MOST | National Natural Science Foundation of China (NSFC)
  • National Key R&D Program of China
  • Major Program of Shenzhen Bay Laboratory

Zitieren

APA

Geng, X., Liu, S., Pan, Y., Ge, Y., & Rao, L. (2026). Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity. Proceedings of the National Academy of Sciences, 123(21). https://doi.org/10.1073/pnas.2529792123

Vancouver

Geng X, Liu S, Pan Y, Ge Y, Rao L. Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity. Proceedings of the National Academy of Sciences. 2026;123(21). doi:10.1073/pnas.2529792123

BibTeX
@article{Geng2026,
  author = {Geng, Xiaorui and Liu, Silan and Pan, Yuanwei and Ge, Yun and Rao, Lang},
  title = {Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {21},
  doi = {10.1073/pnas.2529792123}
}
Kostenlos starten →